Talmapimod
- Generic Name
- Talmapimod
- Drug Type
- Small Molecule
- Chemical Formula
- C27H30ClFN4O3
- CAS Number
- 309913-83-5
- Unique Ingredient Identifier
- B1E00KQ6NT
- Background
Talmapimod is the first-generation oral p38 MAP kinase inhibitor developed by Scios. It has shown to be effective to cure inflammatory diseases such as Rheumatoid Arthritis.
- Indication
Investigated for use/treatment in pain (acute or chronic) and rheumatoid arthritis.
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath